Unicycive Therapeutics, Inc. (UNCY)
Nasdaq: UNCY · Pharmaceutical Preparations · Los Altos, CA · filing with the SEC since 2019
Who runs Unicycive Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Gupta Shalabh K.
CEO. First filing Jul 2021, latest Jun 15, 2026, 0 filings in all.
Officers reporting now
4
of 8 people with a filing in the last fifteen months
Directors reporting now
4
10 people on the record since 2021
Officerssales are open-market, Oct 29, 2025 to Oct 29, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Gupta Shalabh K. | CEO | Jul 2021 | Jun 15, 2026 | none |
| Townsend John | CFO | Jul 2021 | Jun 15, 2026 | none |
| Gupta Pramod | EVP, Pharmaceuticals and BD | Jul 2021 | Jun 15, 2026 | none |
| Jermasek Douglas | EVP, Corporate Strategy | Nov 2022 | Jun 15, 2026 | none |
Directorssales are open-market, Oct 29, 2025 to Oct 29, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Manning Meredith | director | Oct 2026 | Oct 29, 2026 | none |
| Kenkare-Mitra Sara | director | Sep 2023 | Jul 28, 2026 | none |
| Laumas Sandeep | director | Jul 2021 | Jul 28, 2026 | none |
| Aggarwal Gaurav | director | Mar 2023 | Aug 26, 2025 | none |
Earlier names on the record2, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.